Vistin Pharma (VISTIN)

[intravenost]

Trist utvikling i denne aksjen må man vel kunne si.

[TekBot]

23/11-2018 16:09:17: (VISTIN) Mandatory notification of trade

…

Vis børsmeldingen

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sale Valborg Godal Vold holds 50,000 shares in Vistin Pharma ASA.

---

This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vistin Pharma ASA via Globenewswire

http://www.netfonds.no/quotes/release.php?id=20181123.GlobeNewswire.HUG2226799

[zappa66]

Litt seint ute med meldingen da

[TekBot]

11/12-2018 11:00:00: (VISTIN) Financial calendar

Financial calendar for Vistin Pharma ASA

FINANCIAL YEAR 2018
…

Vis børsmeldingen

18.02.2019 - Quarterly Report - Q4

FINANCIAL YEAR 2019

29.08.2019 - Half-yearly Report
22.05.2019 - Annual General Meeting

25.04.2019 - Quarterly Report - Q1
25.10.2019 - Quarterly Report - Q3

This information is published pursuant to the requirements set out in the
Continuing obligations.

http://www.netfonds.no/quotes/release.php?id=20181211.OBI.20181211S26

[TekBot]

18/12-2018 08:12:35: (VISTIN) VISTIN PHARMA ASA (VISTIN) – DISCLOSURE OF SHAREHOLDING

On 17 December 2018, funds managed by QVT Financial LP (“QVT”) sold 494,357
shares in Vistin Pharma ASA, and accordingly, QVT fell below the 5% threshold.

…

Vis børsmeldingen

QVT hereafter owns a total of 1,932,955 shares in Vistin Pharma ASA, or 4.36% of
the registered share capital.

For further information, please contact Meg Eisner of QVT Financial LP at
+1 (212) 705-6229

http://www.netfonds.no/quotes/release.php?id=20181218.OBI.20181218S12

[TekBot]

03/01-2019 17:32:59: (VISTIN) Vistin Pharma ASA : Head of Energy Trading resigns

…

Vis børsmeldingen

Oslo, Norway, 3 January 2019

Torbjørn Kjus, Head of Energy Trading at Vistin Pharma ASA, has decided to resign from his position to pursue other interests.

As a result of the resignation of Torbjørn Kjus, the Board of Directors of Vistin Pharma will evaluate the strategic options available for the Energy Trading division going forward. Further information regarding this business unit will be provided in due course.

*****

For further information, please contact:

Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com

 

 

 

 

 

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

---

This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vistin Pharma ASA via Globenewswire

http://www.netfonds.no/quotes/release.php?id=20190103.GlobeNewswire.HUG2230400

[rayman]

Er glad jeg tok tapet før jul…

[Savepig]

Ville ikke drømme om å kjøpe aksjer i noe Spetalen er involvert i

Enig og tro inntil Dovre faller

[Dressogslips]

Huffameg

[rayman]

Det blir ikke noe flere ganger, lærer av slike smeller også Visste det jo egentlig fra før også, er det som er ser værste

[Janno]

Min beste investering noensinne (hittil) har vært NEL som jo hadde sitt utspring fra Spetalen

Er lov å kjøpe etter at Spetten har solgt seg ut

[pleximus83]

Veldig spesiellt…blir visstnok
ikke noe «IMO 2020» effekt allikevel nå da ser det ut som…

[fuzzy]

Virker egentlig ikke så farlig eller rart ut for min del…

De har jobbet en del med å hente inn kapital for å starte opp ett tradingfond som Kjusern skulle styre.

Det har sikkert ikke lyktes siden de potensielle investorene har vært skvetne pga oljeprisfallet og at IMO posisjonen til Vistin per d.d er såpass i rødt. (NB Dette er 2 separate ting. Posisjoner vs Fondet).

Posisjonene er satt og ifølge Kjus skal vi se bedring i løpet av 2019 før de smeller skikkelig til 2020.

Alle detaljer om posisjonene er så klart ikke kjent, men de har ikke blitt margin called /skviset ut enda og om det “går veien” er det potensielt noen 100 talls mill de kan få ut av de. Kjusern med eller ikke.

Q4 blir nok stygt, men sitter på mine aksjer til dette avklares ordentlig. Alt for stor oppside til at jeg i det hele tatt vurderer å kaste før det.

[TekBot]

04/01-2019 12:52:58: (VISTIN) Vistin Pharma ASA : Trading update for Energy Trading

…

Vis børsmeldingen

Oslo, Norway, 4 January 2019

Reference is made to the announcement yesterday regarding the resignation of Torbjørn Kjus, Head of Energy Trading at Vistin Pharma ASA (“Vistin Pharma” or the “Company”). The Company is in the process of evaluating the strategy for the Energy Trading business unit, and how the current trading positions should be managed going forward.

As previously reported, the Energy Trading business unit has entered into financial derivative contracts to take advantage of the global change in sulphur specifications for marine fuel in the global shipping industry in 2020. The International Maritime Organisation (IMO), which governs the international shipping society, has decided that by 1 January 2020 it will be illegal for any ship to burn fuel with more than 0.5% sulphur content unless the ship can desulphurize the emissions from the fuel (through scrubber equipment). Today, the international shipping fleet mainly burns fuel with 3.5% sulphur content. As a consequence of these regulatory changes, the market anticipates that the market price for fuel with a low sulphur content will increase, while the price for high sulphur fuel will decrease. The oil derivative contracts entered into by Vistin Pharma are based on the price difference between these two fuel qualities.

As of 31 December 2018, the market-to-market value of these contracts was negative NOK 85.0 million, which will be recognised as an unrealised financial loss in 2018. No financial losses or gains relating to these contracts have been realised in 2018. The market-to-market value as of 3 January 2018 was negative NOK 101.3 million. The derivative contracts, which are entered into with a commercial bank as a counter party, do not result in physical delivery of the oil products, but the market-to-market value of the derivatives is settled when the contracts are terminated by Vistin Pharma. The contracts expire at the end of 2020, but may be terminated at any time by the Company.

As part of the agreement for the derivative contracts, a margin call of approximately 20% of the total contract exposure is deposited with the counter party as security. The margin call deposited with the counter party as of 31 December 2018 was NOK 163.5 million. The preliminary consolidated cash and cash equivalents for Vistin Pharma ASA as of 31 December 2018 was NOK 320.6 million, which included the amount deposited as margin call.

Further information regarding the management of the Energy Trading business unit will be provided as soon as the Company’s ongoing evaluation has been finalised.

*****
For further information, please contact:

Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com

 

 

 

 

 

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

---

This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vistin Pharma ASA via Globenewswire

http://www.netfonds.no/quotes/release.php?id=20190104.GlobeNewswire.HUG2230454

[pleximus83]

Få Vistin Pharma tilbake til farmasidelen igjen!

Dette «veddemålet» er bare tull ,-la folket få tilbake utbyttemaskinen igjen!

#MakeVistinGreatAgain

[ole-johan86]

Jeg har problemer med å se hvorfor Kjus slutter og hvorfor Spetalen selger seg ut. Vistin Trading har jo hele tiden vært et bet på 2020 og er fortsatt et bet som kan gi stor uttelling, uanvhengig av urealiserte tap lenge før 2020.

Kan noen forklare meg hva problemet er?

[Storg]

Er ikke de delene solgt?

[Storg]

Ble sikkert dyrere, mer risikofylt enn de klarer å selge inn.

[TekBot]

04/01-2019 16:42:35: (VISTIN) Mandatory notification of trade in Vistin Pharma ASA

On January 4 2019, Saga Tankers ASA, a company controlled by board member
Øystein Stray Spetalen, acquired 768 337 shares at average purchase price of NOK
6.88,- per share.
…

Vis børsmeldingen

After the transaction Øystein Stray Spetalen and associated companies have a
holding of 8 496 285 shares in Vistin Pharma ASA corresponding to 19.16 % of the
outstanding shares.

http://www.netfonds.no/quotes/release.php?id=20190104.OBI.20190104S55

[sulzrox]

Når du skrev “margin call” tenke eg med engang på filmen

Trailer #1 from Margin Call (2011)